Qi Y - Search Results

1

Increased chemokine (C-C motif) ligand 21 expression and its correlation with osteopontin in Graves' disease.

Qi Y, Li X, Zhang Q, Huang F, Lin D, Zhou Y, Hong J, Cui B, Wang W, Ning G, Wang S. Qi Y, et al. Endocrine. 2015 Sep;50(1):123-9. doi: 10.1007/s12020-015-0552-7. Epub 2015 Mar 15. Endocrine. 2015. PMID: 25771884

2

Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy.

Xu YZ, Zhu Y, Shen ZJ, Sheng JY, He HC, Ma G, Qi YC, Zhao JP, Wu YX, Rui WB, Wei Q, Zhou WL, Xie X, Ning G. Xu YZ, et al. Among authors: qi yc. Endocrine. 2011 Dec;40(3):445-51. doi: 10.1007/s12020-011-9502-1. Epub 2011 Jun 25. Endocrine. 2011. PMID: 21706269

3

The expression and pathophysiological role of osteopontin in Graves' disease.

Xu L, Ma X, Wang Y, Li X, Qi Y, Cui B, Li X, Ning G, Wang S. Xu L, et al. Among authors: qi y. J Clin Endocrinol Metab. 2011 Nov;96(11):E1866-70. doi: 10.1210/jc.2011-1339. Epub 2011 Sep 7. J Clin Endocrinol Metab. 2011. PMID: 21900386

4

Expression and diagnostic relevance of heat shock protein 90 and signal transducer and activator of transcription 3 in malignant pheochromocytoma.

Xu Y, Qi Y, Rui W, Zhu Y, Zhang C, Zhao J, Wei Q, Wu Y, Shen Z, Ning G. Xu Y, et al. Among authors: qi y. J Clin Pathol. 2013 Apr;66(4):286-90. doi: 10.1136/jclinpath-2012-201134. Epub 2013 Jan 15. J Clin Pathol. 2013. PMID: 23322822

5

The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias.

Xu Y, Rui W, Qi Y, Zhang C, Zhao J, Wang X, Wu Y, Zhu Q, Shen Z, Ning G, Zhu Y. Xu Y, et al. Among authors: qi y. World J Surg. 2013 Jul;37(7):1626-32. doi: 10.1007/s00268-013-2059-9. World J Surg. 2013. PMID: 23592061

6

The role of osteopontin in the induction of the CD40 ligand in Graves' disease.

Qi Y, Li X, Ma X, Xu L, Zhang X, Jiang X, Hong J, Cui B, Ning G, Wang S. Qi Y, et al. Clin Endocrinol (Oxf). 2014 Jan;80(1):128-34. doi: 10.1111/cen.12229. Epub 2013 Jun 3. Clin Endocrinol (Oxf). 2014. PMID: 23617736

7

Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.

Li X, Qi Y, Ma X, Huang F, Guo H, Jiang X, Hong J, Lin D, Cui B, Ning G, Xu L, Wang S. Li X, et al. Among authors: qi y. PLoS One. 2013 May 22;8(5):e64277. doi: 10.1371/journal.pone.0064277. Print 2013. PLoS One. 2013. PMID: 23717583 Free PMC article.

8

Molecular markers and targeted therapies for adrenocortical carcinoma.

Xu Y, Qi Y, Zhu Y, Ning G, Huang Y. Xu Y, et al. Among authors: qi y. Clin Endocrinol (Oxf). 2014 Feb;80(2):159-68. doi: 10.1111/cen.12358. Epub 2013 Dec 5. Clin Endocrinol (Oxf). 2014. PMID: 24304415 Review.

9

Genetic association between Interleukin-17A gene polymorphisms and the pathogenesis of Graves' disease in the Han Chinese population.

Qi Y, Zheng H, Liu N, Guo T, Zhu W, Wang S, Cui B, Ning G. Qi Y, et al. Clin Endocrinol (Oxf). 2016 Feb;84(2):265-270. doi: 10.1111/cen.12725. Epub 2015 Feb 24. Clin Endocrinol (Oxf). 2016. PMID: 25597472

10

Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma.

Xu L, Qi Y, Xu Y, Lian J, Wang X, Ning G, Wang W, Zhu Y. Xu L, et al. Among authors: qi y. Oncotarget. 2016 Jun 14;7(24):36235-36246. doi: 10.18632/oncotarget.8827. Oncotarget. 2016. PMID: 27105537 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,141 results

Search Page

Filters